![]() |
Visiting Professor / MD, DrPH 渋谷 健司 |
Areas of interest
Health policy, health economics, demography, statistics, epidemiology ![]() |
Career
2019-present | Visiting Professor, Department of Global Health Policy, Graduate School of Medicine, The University of Tokyo |
2008-2019 | Professor and Chair, Department of Global Health Policy, Graduate School of Medicine, The University of Tokyo |
2004-2008 | Coordinator, Health Statistics and Evidence, Measurement and Health Information Systems, Evidence and Information for Policy, World Health Organization |
2001-2004 | Senior Scientist, Global Programme on Evidence for Health Policy, Evidence and Information for Policy, World Health Organization |
1999-2001 | Assistant Professor of Public Health and Policy, Department of Hygiene and Public Health, Teikyo University School of Medicine |
1999 | DrPH in International Health Economics, Harvard University School of Public Health |
1993-1999 | Research Fellow, Burden of Disease Unit, Harvard Center for Population and Development Studies |
1995 | MSc in International Health Policy and Economics, Harvard University School of Public Health |
1994 | MPH in International Health, Harvard University School of Public Health |
1993-1999 | Medical Doctor, University of Tokyo and Teikyo University Hospitals |
1991-1993 | Resident, Teikyo University Ichihara Hospital |
1991 | MD, The University of Tokyo. |
Publications
GBD 2017 Risk Factor Collaborators.Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018; 392(10159), P1923-1994.
GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018; 392(10159), P1859-1922.
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 . The Lancet. 2018; 392(10159), P1789-1858.
GBD 2017 Mortality Collaborators. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018; 392(10159), P1684-1735.
Otsuki S , Saito E, Sawada N, Abe SK Hidaka A, Yamaji T, Shimazu T, Goto A, Iwasaki M, Iso H, Mizoue T, Shibuya K , Inoue M, Tsugane S. Female reproductive factors and risk of all-cause and cause-specific mortality among women: The Japan Public Health Center-based Prospective Study (JPHC study). Annals of Epidemiology. 2018. Online first.
Nishi A, Singkham P, Takasaki Y, Ichikawa M, Chadbunchachai W, Shibuya K, Tanasugarn C. Motorcycle helmet use to reduce road traffic deaths in Thailand. Bulletin of the World Health Organization. 2018;96:514-514A.
Han SM, Rahman MM, Rahman MS, Swe KT, Palmer M, Sakamoto H, Nomura S, Shibuya K. Progress towards universal health coverage in Myanmar: a national and subnational assessment. The Lancet Global Health. 2018; 9: e989-e997.
Sakamoto H , Ezoe S, Hara K, Hinoshita E, Sekitani Y, Abe K, Inada H, Kato T, Komada K, Miyakawa M, Yamaya H, Yamamoto N, Abe SK, Shibuya K. The G7 presidency and universal health coverage, Japan’s contribution . Bulletin of the World Health Organization. 2018; 96:355–359.
Swe KT, Rahman MM, Rahman MS, Saito E, Abe SK, Gilmour S, Shibuya K. Cost and economic burden of illness over 15 years in Nepal: A comparative analysis. PLoS ONE. 2018; 13(4): e0194564.
Nomura S, Shibuya K. Improving Population Health in the Era of Superaging: Japan’s Challenges and Opportunities. In: Sean Connell, Shuhei Nomura, Kenji Shibuya and Benjamin Shobert. Innovative Asia: Innovation Policy and the Implications for Healthcare and the Life Sciences. Washington: The National Bureau of Asian Research; 2018.